Role of Myo-Inositol in Treatment of Young Females Affected By Polycystic Ovarian Syndrome: Quasi Experimental Study
DOI:
https://doi.org/10.51985/JBUMDC2019092Abstract
Study Design and Setting: This was a quasi-experimental study and was conducted in United Medical and Dental College
and Creek General Hospital from January 2017 to January 2018.
Methodology: Total 100 patients were recruited based on the specific inclusion criteria of PCO diagnosed by symptoms
(body mass index, menstrual irregularity, hirsutism, acne) biochemical markers (fasting insulin, random blood sugar) and
ultrasound findings. Each subject in the study group was given sachet (Myo- inositol 2000mg and folic acid 400ug) once
a day dissolved in glass of water for duration of 6 months. Improvement in symptoms, biochemical markers and ultrasound
findings were reassessed after the completion of 6 months duration. The SPSS version 21 was used for data analysis. The
paired T test was used to assess the effects of Myo-Inositol before treatment and after six months of treatment.
Result: The significant relation (0.001) was observed between the intervention and PCO and its related symptoms. An
evident effect was noticed in each individual after the intervention was provided to them. The relatable symptoms such
as irregularities in menses, hirsutism,weight and insulin resistance were reduced by significant ratio.
Conclusion: Myo – inositol has proven to be effective in reducing the PCO and its relatable symptoms in young females.
Despite the limitations, enough evidence was collected that indicated a significant effect of the intervention.
References
Haqq L, McFarlane J, Dieberg G, Smart N. The effect of
lifestyle intervention on body composition, glycemic control,
and cardiorespiratory fitness in polycystic ovarian syndrome:
a systematic review and meta-analysis. International journal
of sport nutrition and exercise metabolism. 2015;25(6):533-
William T, Mortada R, Porter S. Diagnosis and Treatment of
Polycystic Ovary Syndrome.American family physician.2016;
(2):106-113 ·
De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante
G, Petraglia F. Genetic, hormonal and metabolic aspects of
PCOS: an update. Reproductive Biology and Endocrinology.
;14(1)
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic Ovarian
Syndrome: Correlation Between Hyperandrogenism, Insulin
Resistance and Obesity.Clin Chim Acta. 2019 Nov 13. pii:
S0009-8981(19)32118-7.
Gateva A, Unfer V, Kamenov Z. The use of inositol (s) isomers
in the management of polycystic ovary syndrome: a
comprehensive review. Gynecological Endocrinology.
;34(7):545-50.
Tagliaferri V, Romualdi D, Immediata V, De Cicco S, Di
Florio C, Lanzone A, Guido M, Metformin vs myoinositol:
which is better in obese polycystic ovary syndrome patients?
A randomized controlled crossover study. Clin Endocrinol
(Oxf). 2017;86(5):725-730.
Pasquali R, Diamanti-Kandarakis E, Gambineri A.
Management of endocrine disease: secondary polycystic ovary
syndrome: theoretical and practical aspects. European journal
of endocrinology. 2016;175(4):R157-R69.
Sortino MA, Salomone S, Carruba MO, Drago F. Polycystic
Ovary Syndrome: Insights into the Therapeutic Approach
with Inositols. . Front Pharmacol. 2017;8:341.
Regidor PA, Schindler AE, Lesoine B, Druckman R.
Management of women with PCOS using myo-inositol and
folic acid. New clinical data and review of the literature.
Horm Mol Biol Clin Investig. 2018;34(2)
Facchinetti F, Bizzarri M, Benvenga S, D’Anna R, Lanzone
A, Soulage C, et al. Results from the International Consensus
Conference on Myo-inositol and d-chiro-inositol in Obstetrics
and Gynecology: the link between metabolic syndrome and
PCOS. European Journal of Obstetrics & Gynecology and
Reproductive Biology. 2015;195:72-6.
Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol
in Polycystic Ovary Syndrome: Restoring Fertility through
a Pathophysiology-Based Approach. Trends Endocrinol Metab.
Nov;29(11):768-780.
Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic
Ovary Syndrome (PCOS): The Hypothesis of PCOS as
Functional Ovarian Hyperandrogenism Revisited. Endocr
Rev. 2016;37(5):467-520.
Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari
FR, Ghasemi V, The prevalence of polycystic ovary syndrome
in adolescents: A systematic review and meta-analysis. Int J
Reprod Biomed (Yazd). 2019;17(8):533-542.
Wang FF, Wu Y ,Zhu YH, Ding T, Batterham RL, Qu F,
Hardiman PJ. Pharmacologic therapy to induce weight loss
in women who have obesity/overweight with polycystic ovary
syndrome: a systematic review and network meta-analysis.
Obes Rev. 2018 Oct;19(10):1424-1445.
Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos
Prapas and Fabio Facchinetti. Effects of Inositol(s) in Women
with PCOS: A Systematic Review of Randomized Controlled
Trials. Int J Endocrinol. 2016; 2016: 1849162.
Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/Dchiro-
inositol plasma ratio is able to restore ovulation in PCOS
patients: comparison with other ratios. Eur Rev Med Pharmacol
Sci. 2019;23(12):5512-21.Bevilacqua A ,Bizzarri M. Inositols in Insulin Signaling and
Glucose Metabolism. Int J Endocrinol. 2018 Nov 25.
Nas K, Tûû L. A comparative study between myo-inositol
and metformin in the treatment of insulin-resistant women.
Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):77-82.
Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli
RA, Gullo G, Granese R, Triolo O. Metabolism and Ovarian
Function in PCOS Women: A Therapeutic Approach with
Inositols. Int J Endocrinol. 2016; 2016:6306410.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS,
et al. Polycystic ovary syndrome. Nature reviews Disease
primers. 2016;2:16057.
Advani K, Batra M, Tajpuriya S, Gupta R, Saraswat A, Nagar
HD, Makwana L, Kshirsagar S, Kaul P, Kumar Ghosh A,
Pradhan S, Mehta A, Jaiswal A, Nakhate KT, Kamdi S.
Efficacy of combination therapy of inositols, antioxidants and
vitamins in obese and non-obese women with polycystic
ovary syndrome: an observational study.J Obstet Gynaecol.
Jul 24:1-6.
McBreairty LE, Kazemi M, Chilibeck PD, Gordon JJ, Chizen
DR, Zello GA.Effect of a pulse-based diet and aerobic exercise
on bone measures and body composition in women with
polycystic ovary syndrome: A randomized controlled trial.
Bone Rep. 2020 Jan 23;12
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Haniyah Qamar; Rozina Mustafa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
